CI vs TVTX · P/E 2.4, rev $274.90B vs rev $233.2M
Cigna Corp (CI) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the CI and TVTX stock pages for the full models.
Not investment advice.